Additional Resources

• International Working Group (IWG) Response Criteria for MDS
• Dose Modification Guidelines for Lenalidomide in MDS
• Key Concepts in the Treatment of MDS
• FDA-Approved Agents for Treatment of MDS: Drug Profiles and Safety Guidelines
• MDS Treatment Algorithms
• Risk-Based Stratification of MDS Based on the International Prognostic Scoring System (IPSS) and Proposed Modifications
• Scientific Developments in MDS
• Therapeutic Targets and Novel Therapies in MDS
• WHO Reclassification of FAB Subtypes of MDS
• Patient and Nursing Resources
• Disease Snapshot